scholarly journals SPIRE: A phase Ib/ randomised IIa open label clinical trial combining guadecitabine with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer

2018 ◽  
Vol 29 ◽  
pp. viii139
Author(s):  
S.J. Crabb ◽  
S.J. Danson ◽  
D. Dunkley ◽  
M. Kalevras ◽  
A. Whitehead ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bladder Cancer ◽  
Open Label ◽  
Phase Ib ◽  
Solid Malignancies

SPIRE: A phase Ib/randomised IIa open label clinical trial combining guadecitabine (SGI-110) with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS4594-TPS4594
Author(s):  
Simon J. Crabb ◽  
Sarah Danson ◽  
James Catto ◽  
Cathy McDowell ◽  
Denise Dunkley ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bladder Cancer ◽  
Open Label ◽  
Phase Ib ◽  
Solid Malignancies

scholarly journals Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

2021 ◽  
Vol 22 (1) ◽  
pp. 107-117 ◽  
Author(s):  
Stephen A Boorjian ◽  
Mehrdad Alemozaffar ◽  
Badrinath R Konety ◽  
Neal D Shore ◽  
Leonard G Gomella ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Gene Therapy ◽  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Repeat Dose ◽  
Open Label ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

scholarly journals A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26 –104/ RFASE in Patients with Advanced Solid Malignancies

2020 ◽  
Author(s):  
Ruben S.A. Goedegebuure ◽  
Madelon Q. Wentink ◽  
Hans J. Vliet ◽  
Peter Timmerman ◽  
Arjan W. Griffioen ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Therapeutic Vaccine ◽  
Open Label ◽  
Solid Malignancies
Sign in / Sign up

Export Citation Format

Share Document